Role of PXR Signaling in Mediating the Cardioprotective Effects of  -3 Fatty Acids Saraswathi Viswanathan, Ph.D. Assistant Professor Department of Internal.

Slides:



Advertisements
Similar presentations
Immune Activation/Inflammation and HIV Disease Prof. Georg Behrens Department for Clinical Immunology and Rheumatology Hannover Medical School Germany.
Advertisements

Walter Lab: Gut microbiome and its interactions with metabolic disease
Biology of Lipid Metabolism Laboratory. People Lab head Matthew Watt Research Assistant Maria Matzaris.
Anti-Lipemic Mechanism of (R)-α-Lipoic Acid (LA) Regis Moreau, Ph.D. Assistant Professor Department of Nutrition and Health Sciences University of Nebraska-Lincoln.
Dietary Selenium Deficiency Partially Rescues Type 2 Diabetes–Like Phenotypes of Glutathione Peroxidase-1 Overexpressing Male Mice Dietary Selenium Deficiency.
Chapter 5 The Lipids: Fats, Oils, Phospholipids, and Sterols
Omega 3 Fatty Acids in Parenteral Nutrition Erin Buehler Lauryn Whitfield.
LDL Cholesterol Goals and Cutpoints for Therapeutic Lifestyle Changes (TLC) and Drug Therapy in Different Risk Categories Risk Category LDL Goal (mg/dL)
Fish Oils Denesh, Alan. Shane, Vince What are Fish Oils? Fish oils provides the essential fatty acids needed for important biological compounds They.
Endocrine Block | 1 Lecture | Dr. Usman Ghani
By Hussam A.S. Murad and Khaled A. Mahmoud Department of Pharmacology and Therapeutics Faculty of Medicine, Ain Shams University By Hussam A.S. Murad.
Nutrition & Heart Disease Key Concepts and Facts Heart disease is leading cause of death Dietary and lifestyle factors are important Diets that provide.
Obesity Dr. Sumbul Fatma. Obesity A disorder of body weight regulatory systems Causes accumulation of excess body fat >20% of normal body weight Obesity.
Lecture 5b 3 Feb 2014 Atherosclerosis-Nutritional intervention- -emphasis should be on prevention-
cardio protection: Focus on
Effects on lipid levels and lipid metabolism under more human-like conditions. –Lipid levels, cholesterol synthesis and cholesterol absorption. Effects.
4 th Global Summit on Toxicology Philadelphia, PA, USA Aug , 2015.
Sonia M.S. Espirito Santo, Bart J.M. van Vlijmen, Rien Buytenhek, Wim van Duyvenvoorde, Erik H. Offerman, Louis M. Havekes and Hans M.G. Princen Gaubius.
Plasminogen-Activating Inhibitor-1 (PAI-1) High PAI-1 associated with: Obesity (especially visceral), possible fatty liver. 2,3,4 Inflammation and oxidative.
Dietary fish oil modulates the effect of dimethylhydrazine-induced colon cancer in rats By G.E. Rasmy, W.K.B. Khalil, S.A. Moharib, A.A. Kawkab, and E.W.
The Road To Metabolic syndrome
Long chain polyunsaturated fatty acids and inflammation
Obesity Dr. Sumbul Fatma. Obesity A disorder of body weight regulatory systems Causes accumulation of excess body fat >20% of normal body weight Obesity.
Metabolic Syndrome: Focused on AMPK as Molecular Target for Metabolic Syndrome Bayu Lestari.
Sources of Omega-3’s: Supplements vs. Food Suzanne Hotchkiss NUTR 421 Macronutrient Metabolism.
Diet Study for Nonalcoholic Fatty Liver Disease Lab meeting.
Lipids and Parenteral Nutrition. Disclosures Patent application submitted for Omegaven ® use.
Date of download: 6/2/2016 Copyright © The American College of Cardiology. All rights reserved. From: Omega-3 Fatty Acids and Cardiovascular Disease: Effects.
MargiAnne Isaia, MD MPH Advanced Nutrition Lipids 3.
Prophylaxis of Coronary Heart Disease: Drugs That Help Normalize Cholesterol and Triglyceride Levels.
1 A Comparison of Lipid and Glycemic Effects of Pioglitazone and Rosiglitazone in Patients With Type 2 Diabetes and Dyslipidemia Diabetes Care 28:1547–1554,
TODAY’S MENU 1.Why is fat good for us? 2.Ketones and Ketosis 3. Cholesterol: Friend or Foe? 4. What do my cholesterol blood tests mean? 5. Which fats to.
PPAR δ : a dragger in the heart of the metabolic syndrome J.Clin.Invest.116:590~597(2006) R3 Song Se-bin Grant D. Barish, Vihang A.Narkar, and Ronald M.Evans.
Novel insights into regulation of plasma triglyceride levels
Note Final Exam-please check final schedule.
Role of thyroid hormone homeostasis in obesity-prone and obesity-resistant mice fed a high-fat diet  Shu-Fang Xia, Xiao-Mei Duan, Li-Yue Hao, Li-Ting.
Chapter 7 Metabolic syndrome
Micro-RNAs, Fatty Acids and Insulin Secretion
Obesity Dr. Sumbul Fatma.
Go Woon Kim, Hee Kyung Jo, Sung Hyun Chung  Journal of Ginseng Research 
Question: Could diabetes be drivens by our bones?
ASSOCIATIONS OF METABOLIC SYNDROME COMPONENTS WITH CRITERIA FOR THE CLINICAL DIAGNOSIS OF THE METABOLIC SYNDROME AS PROPOSED BY THE NCEP-ATP III Metabolic.
Michael B. Zemel, Ph.D. Chief Scientific Officer NuSirt Biopharma
Micro-RNA 132 and 212 mediated regulation of fatty acid metabolism and its effect on insulin secretion. Prelim Mock Talk by -Mufaddal S Soni Attie Lab.
Lipids in Health and Disease
Lipids in Health and Disease
Repeat fasting lipid profile to confirm in 1-2 weeks
Back to the Basics of Dyslipidemia
The Chemical Differences Between EPA and DHA.
Nutrigenomics KNH 413.
Genetics and epigenetics of NAFLD and NASH
Nuclear Receptors as Drug Targets in Cholestatic Liver Diseases
The Chemical Differences Between EPA and DHA.
Nonalcoholic steatohepatitis
Nutrigenomics KNH 413.
Nutrigenomics KNH 413.
Nutrigenomics KNH 413.
Ludger Scheja, Joerg Heeren  Journal of Hepatology 
Volume 141, Issue 4, Pages e5 (October 2011)
Figure 2 Microbiota-related pathways in atherosclerosis
Lipids in Health and Disease
Chapter 7 LIPIDS IN HEALTH & DISEASE
Volume 19, Issue 2, Pages (February 2014)
Lecture 5b 7 Feb 2011 Atherosclerosis-Nutritional intervention-
Toshimasa Yamauchi, Takashi Kadowaki  Cell Metabolism 
CHD RISK Glycemia 75g OGTT Time Metabolic Syndrome
Nutrigenomics KNH 413.
Nutrigenomics KNH 413.
Sander Lefere, Frank Tacke  JHEP Reports 
Specific Dyslipidemias: Very High LDL Cholesterol (>190 mg/dL)
Presentation transcript:

Role of PXR Signaling in Mediating the Cardioprotective Effects of  -3 Fatty Acids Saraswathi Viswanathan, Ph.D. Assistant Professor Department of Internal Medicine/DEM University of Nebraska Medical Center-Omaha

Abdominal obesity Atherogenic dyslipidemia Insulin resistance Elevated blood pressure Pro-inflammatory state Metabolic Syndrome and CVD

Fish Oil and  -3 PUFAs EPA-Eicosapentaenoic acid DHA-Docosahexaenoic acid Fish Oil and  -3 Fatty Acids

30 g of fish per week reduced caronary artery disease (Kromhout DBE, 1985). EPA&DHA reduced plasma TG and non- HDL cholesterol in patients with type 2 diabetes and dyslipidemia (De Luis, DA 2009).  -3 fatty acids reduced plasma TG, total cholesterol without altering glycemic index (Sirtori CR, 1998). Clinical Evidence for the Beneficial Effects of Fish Oil

Mechanisms TG-Lowering Effect Reduced TG secretion Increased TG clearance Increased  -oxidation

Mechanisms Mediating the Cholesterol-Lowering Effects Cholesterol Bile acid CYP 7A1 CYP 27A1 CYP 11A CYP 3A Bile acid Detoxification Sulfotransferases Glutathione S transferases Cholesterol hydroxylation CYP3A Sult1e1 Sult2a1 Sult3e1 Gsta1 Gsta2 PXR

Interference with arachidonic acid metabolism COX-derived 3-series eicosanoids LOX-derived resolvins Cytochrome P450-derived epoxides Mechanisms Mediating the Anti- Inflammatory Effects of  -3s

PXR and Inflammation PXR CYP 2C and CYP 3A  -3 epoxides  -3 FAs Anti- inflammatory

PXR Drug detoxification Bile acid homeostasis Cholesterol metabolism Reduce inflammation

Effect of Fish Oil on Plasma Lipids n=13-15 per group; ^P<0.001 vs OO OO-Olive Oil, FO-Fish Oil Preliminary Data

Effect of Fish Oil on Hepatic Steatosis n=4-10 per group; ^P<0.001 vs OO OO-Olive Oil, FO-Fish Oil

Effect of Fish Oil on Inflammatory Genes in Liver n=5-6 per group; ^P<0.001 and # P<0.01 vs OO OO-Olive Oil, FO-Fish Oil

Genes Upregulated in Liver upon Fish Oil Feeding-Microarray Analysis GenesFold Increase CYP3A441.6 CYP2C681.6 Sult 1e12.2 Sult 1b12.0 Sult 3a11.8 GSTA12.2 GSTA21.6

Effect of Fish Oil on PXR and CYP3A in Liver OO,Olive Oil; FO, Fish Oil, n=5-6 samples per group, # P<0.01 vs OO

Anti-inflammatory Effects Cholesterol- lowering Effects  -3 Fatty Acids (EPA & DHA) Cardioprotective Effects Hypothesis PXR Overall Hypothesis: The cholesterol-lowering and anti- inflammatory effects of  -3 fatty acids are mediated via PXR.

Specific Aims Specific Aim 1: To determine the role of PXR in mediating the cholesterol-lowering and anti-inflammatory effects of  -3 fatty acids in a model of diet-induced obesity and dyslipidemia. Specific Aim 2: To determine the role of PXR in mediating the cholesterol-lowering and anti-atherosclerotic effects of  -3 fatty acids in a model of genetic dyslipidemia. Specific Aim 3: To determine whether the  -3 fatty acids modulate PXR signaling in cultured hepatocytes.

Mutant-PXR-/- WT-PXR+/+ Experimental Design-Specific Aim 1 High Fat Diet 45% Fat (energy) 1% Cholesterol 0.56%  -3s Chow Diet 0.56% Oleic Acid 0.56%  -3s Chow Diet 0.56% Oleic Acid Chow Diet Study Groups Experimental Diets

Proposed Experiments-Specific Aim 1 Lipid profiles in plasma and liver Expression of genes/proteins involved in cholesterol/bile acid metabolism and inflammatory response Analysis of gall bladder bile for cholesterol and phospholipids Levels of  -3 epoxide metabolites in liver

LDLR;PXR-/- LDLR-/- Experimental Design-Specific Aim 2 High Fat Diet 40% Fat (energy) 0.5% Cholesterol 0.56%  -3s Chow Diet 0.56% Oleic Acid 0.56%  -3s Chow Diet 0.56% Oleic Acid Chow Diet Study Groups Experimental Diets

Proposed Experiments-Specific Aim 2 Lipid profiles in plasma and liver Genes involved in cholesterol/bile acid metabolism and inflammatory response Analysis of gall bladder bile for cholesterol and phospholipids Atherosclerotic lesion area

Inflammation Apoptosis Bile Acid Detoxification Bile Acid Detoxification PXR Signaling LCA+  -3s LCA Experimental Design-Specific Aim 3 Primary Hepatocytes from WT and PXR-/- Mice

Apoptosis  Experimental Design-Specific Aim 3 LCA Human HepG2 Cell Line  -3s Scrambled siRNA for PXR siRNA for PXR Inflammation  Apoptosis  Inflammation 

Summary  -3 Fatty Acids (EPA & DHA) PXR Signaling CYP 2C & CYP 3A Cholesterol & Bile Acid Metabolism  3-Epoxides Lipid-lowering Effects Anti-inflammatory Effects Anti-atherosclerotic Effects Genetic Dyslipidemia Dyslipidemia in Obesity Liver Hepatocyte Inflammation & Apoptosis SA1 SA2 SA3

Impact Identification of novel molecular mechanisms by which  - 3 fatty acids mediate their cholesterol-lowering and anti- inflammatory effects. The findings will be critical to target PXR using dietary factors to efficiently prevent/treat dyslipidemia in humans without adverse side effects.